Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations

被引:1
|
作者
Feng, J. [1 ]
Hueniken, K. [2 ]
Fan, Z. [1 ]
Faour, E. [1 ]
Corke, L. [1 ]
Leighl, N. [1 ]
Liu, G. [1 ]
Bradbury, P. [1 ]
Sacher, A.
Eng, L.
Stockley, T. [3 ]
Tsao, M-S. [1 ]
Shepherd, F. A. [1 ]
机构
[1] UHN Univ Hlth Network, Med Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] UHN Univ Hlth Network, Biostast, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] UHN Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
关键词
D O I
10.1016/j.annonc.2023.09.2386
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1353P
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Prognostic and predictive effects of TP53 mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
    Labbe, Catherine
    Korpanty, Grzegorz
    Tomasini, Pascale
    Doherty, Mark
    Mascaux, Celine
    Jao, Kevin
    Pitcher, Bethany
    Pintilie, Melania
    Leighl, Natasha B.
    Feld, Ronald
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Kamel-Reid, Suzanne
    Tsao, Ming Sound
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Association of TP53 mutation status with clinical outcomes stratified by sensitive and non sensitive EGFR mutation, in non-small cell lung cancer (NSCLC).
    Ahmed, Saman
    Aggarwal, Charu
    Mick, Rosemarie
    Sterlicchi, Trisha M.
    Kadauke, Stephan
    Gault, Christofer
    Cohen, Roger B.
    Evans, Tracey L.
    Bauml, Joshua
    Deshpande, Charuhas
    Torigian, Drew A.
    Udupa, Jayaram
    Langer, Corey J.
    Morrissette, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Poor prognosis of concurrent KRAS and TP53 mutations in patients with resected non-squamous non-small cell lung cancer (NSCLC)
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Fabre, E.
    Blons, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S813 - S813
  • [24] Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer
    Bae, Eun Young
    Lee, Eun Jin
    Kang, Hyo-Gyoung
    Lee, Shin Yup
    Jin, Gwang
    Lee, Won Kee
    Choi, Jin Eun
    Jeon, Hyo-Sung
    Lim, Jeong Ok
    Lee, Eung Bae
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (11) : 1527 - 1530
  • [25] Association of TP53 Mutations with Response to Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer
    Fang, Shencun
    Cheng, Wanwan
    Zhang, Meiling
    Yang, Rusong
    ONCOTARGETS AND THERAPY, 2020, 13 : 6645 - 6650
  • [26] A Novel TP53 Gene Mutation Sustains Non-Small Cell Lung Cancer through Mitophagy
    Wang, Yuanli
    Goh, Kah Yong
    Chen, Zhencheng
    Lee, Wen Xing
    Choy, Sze Mun
    Fong, Jia Xin
    Wong, Yun Ka
    Li, Dongxia
    Hu, Fangrong
    Tang, Hong-Wen
    CELLS, 2022, 11 (22)
  • [27] Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer
    Zhu, Lihuan
    Zhou, Dongsheng
    Chen, Yiyong
    Guo, Tianxing
    Chen, Wenshu
    Pan, Xiaojie
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [28] ONCOGENIC DRIVER MUTATIONS IN CHINESE NON-SMALL CELL LUNG CANCER (NSCLC)
    He, J.
    Yang, H.
    Deng, Q.
    He, P.
    Jiang, J.
    Zhao, M.
    Gu, X.
    Zheng, L.
    Pang, H.
    Zhou, J. X.
    ANNALS OF ONCOLOGY, 2012, 23 : 389 - 390
  • [29] Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma
    Ying, Kaijun
    Zou, Li
    Wang, Daquan
    Wang, Rao
    Qian, Jun
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (18) : 2699 - 2711
  • [30] TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Citarella, F.
    Russano, M.
    Fiorenti, M.
    La Cava, G.
    Pizzutilo, E. G.
    Martinelli, F.
    Pierri, S.
    Russo, A.
    Muscolino, P.
    Sapuppo, E.
    Marinello, A.
    Aldea, M.
    Besse, B.
    Filetti, M.
    Lombardi, P.
    Vitale, A.
    Buzzacchino, F.
    Cristofani, L.
    Lugini, A.
    Cortellini, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S848 - S848